Protalix Biotherapeutics Long Term Deferred Charges (Quarterly) Analysis

Protalix Biotherapeutics, Inc. (PLX)

1.77 -0.02 (-1.12%) USD | NYAM | Jan 06, 16:00

1.765 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for PLX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

PAVmed, Inc.	--
Denali Therapeutics, Inc.	--
AIM ImmunoTech, Inc.	--
Perspective Therapeutics, Inc.	--
Armata Pharmaceuticals, Inc.	--